Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Busse

Showing results (771-780 of 932) with videos related to

Pageof 94
Sort By:
BMJ (Clinical Research Ed.)|September 9, 2021
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trialsLi Wang, Patrick J Hong, Curtis May, et al.
Plos One|July 8, 2017
Endotypes of difficult-to-control asthma in inner-city African American childrenK R Brown, R Z Krouse, A Calatroni, et al.
Lancet (London, England)|September 23, 2008
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trialStanley J Szefler, Herman Mitchell, Christine A Sorkness, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2012
Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescentsJeremy J Wildfire, Peter J Gergen, Christine A Sorkness, et al.
The New England Journal of Medicine|March 18, 2011
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city childrenWilliam W Busse, Wayne J Morgan, Peter J Gergen, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2017
Obstruction phenotype as a predictor of asthma severity and instability in childrenRonald L Sorkness, Edward M Zoratti, Meyer Kattan, et al.
Annals of Intensive Care|December 16, 2023
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockDaniel E Leisman, Damian R Handisides, Lakhmir S Chawla, et al.
Journal of Clinical Epidemiology|June 2, 2022
A meta-research study of randomized controlled trials found infrequent and delayed availability of protocolsChristof Manuel Schönenberger, Alexandra Griessbach, Ala Taji Heravi, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent AsthmaWilliam J Sheehan, Rebecca Z Krouse, Agustin Calatroni, et al.
Pageof 94

Showing results (771-780 of 932) with videos related to

Sort By:
Pageof 94
BMJ (Clinical Research Ed.)|September 9, 2021
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trialsLi Wang, Patrick J Hong, Curtis May, et al.
Plos One|July 8, 2017
Endotypes of difficult-to-control asthma in inner-city African American childrenK R Brown, R Z Krouse, A Calatroni, et al.
Lancet (London, England)|September 23, 2008
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trialStanley J Szefler, Herman Mitchell, Christine A Sorkness, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2012
Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescentsJeremy J Wildfire, Peter J Gergen, Christine A Sorkness, et al.
The New England Journal of Medicine|March 18, 2011
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city childrenWilliam W Busse, Wayne J Morgan, Peter J Gergen, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2017
Obstruction phenotype as a predictor of asthma severity and instability in childrenRonald L Sorkness, Edward M Zoratti, Meyer Kattan, et al.
Annals of Intensive Care|December 16, 2023
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockDaniel E Leisman, Damian R Handisides, Lakhmir S Chawla, et al.
Journal of Clinical Epidemiology|June 2, 2022
A meta-research study of randomized controlled trials found infrequent and delayed availability of protocolsChristof Manuel Schönenberger, Alexandra Griessbach, Ala Taji Heravi, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2020
Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent AsthmaWilliam J Sheehan, Rebecca Z Krouse, Agustin Calatroni, et al.
Pageof 94